Objective To compare the effectiveness of customized vs population-based growth charts for the prediction of adverse pregnancy outcomes. (odds ratio (OR), 7.8 (95% CI,3)), neonatal death (OR, 3.5 (95% CI,), perinatal death (OR, 5.8 (95% CI, and NICU admission (OR, 3.6 (95% CI, (OR, 4.0 (95% CI,) and NICU admission (OR, 2.4 (95% CI, (OR, 7.4 (95% CI, OR, 8.0 (95% CI,.1) using population-based charts). 
INTRODUCTION
Deviations in fetal growth, and secondarily birth weight, are associated with adverse pregnancy outcomes, and infants born small-for-gestational age (SGA; birth weight < 10 th centile) or large-for-gestational age (LGA; birth weight > 90 th centile) may be at increased risk of short-as well as long-term adverse health outcomes [1] [2] [3] [4] [5] [6] . Birth weight is determined by a combination of genetic, intrauterine and environmental influences; traditionally, evaluation of fetal growth has been addressed by comparing estimated fetal weight with population-based norms that are derived from either heterogeneous or highly selected patient cohorts and do not account for individual variability [6] [7] [8] . Population-based norms do not differentiate between abnormal growth and constitutionally large or small, but otherwise healthy, fetuses. Relying on these norms can therefore lead to misclassification of birth weight and over-or underdiagnosis of fetal growth abnormalities 9, 10 . In order to circumvent the limitations of population-based standards, a number of customized norms have been developed. Customized norms model optimal fetal growth by accounting for individual variables that are known to affect growth, as they allow measurement of deviations from an ideal fetal growth potential, rather than deviations from an expected norm for a population 10 . One of the more widely used models is that of Gardosi et al. [10] [11] [12] . As abnormal fetal growth has been associated with adverse neonatal outcomes, early studies showed how customized models can better identify neonates at risk [13] [14] [15] [16] ; however, more recent reports do not support such conclusions [17] [18] [19] . Our goal was to perform a systematic review of the published data regarding customized and population-based growth charts in order to determine which classification has the strongest association with adverse outcomes when birth weight is outside the norm. Therefore, we conducted a Bayesian meta-analysis to compare the risk of intrauterine fetal demise (IUFD), neonatal mortality, perinatal mortality and admission to the neonatal intensive care unit (NICU) among SGA neonates, classified with customized or population-based approaches, when compared with non-SGA neonates. Similarly, we investigated the risk of perinatal mortality, NICU admission, neonatal hypoglycemia, maternal third-and fourth-degree perineal lacerations and neonatal shoulder dystocia among LGA pregnancies classified according to customized vs population-based growth charts, when compared with non-LGA pregnancies.
METHODS

Information sources
An electronic search of MEDLINE, ClinicalTrials.gov (www.clinicaltrials.gov) and The Cochrane Collaboration databases was performed from inception to 31 May 2016, using a combination of text words including 'customized fetal growth', 'customized growth chart', 'customized birth weight', 'customized antenatal growth charts', 'pregnancy', 'antenatal', 'growth' and 'customized'.
Eligibility criteria
Studies were included if they compared adverse neonatal or maternal outcomes among SGA or LGA neonates, defined according to both customized and population-based norms.
Study selection
As customized norms have been used to address different adverse perinatal outcomes in the setting of fetal growth disturbance, the initial step consisted of identifying such outcomes in the eligible studies. Two reviewers (G.C. and M.M.C.) evaluated independently the titles and abstracts of all citations produced by the electronic searches. Studies were included in the final analysis if they classified LGA and SGA by population-based and customized approaches, if they compared adverse perinatal outcomes among LGA and SGA neonates and if perinatal outcomes were considered clinically relevant by the reviewers and were reported in more than one study. Studies were excluded if they did not meet all the abovementioned criteria. We chose to study perinatal mortality and NICU admission among SGA and LGA neonates. We investigated IUFD and neonatal mortality among SGA neonates, and shoulder dystocia, maternal third-and fourth-degree perineal lacerations and neonatal hypoglycemia among LGA neonates only. Although clinically relevant, we did not consider the following as potential study outcomes: composite neonatal outcomes, preterm delivery, placental abruption, duration of NICU stay and hypertensive disorders, as they represent heterogeneous groups that were classified differently in the various studies. We did not include Cesarean delivery among our study outcomes, as both macrosomic and growth-restricted fetuses have a higher likelihood of Cesarean delivery, but Cesarean delivery can also be performed electively owing to such diagnoses 5 . Finally, we chose not to consider Apgar scores, umbilical-cord blood pH and neonatal resuscitation as outcomes, as they may depend on multiple factors other than fetal-growth patterns.
Discordance between reviewers was resolved by discussion or, if not possible, by consultation with a third author (G.R.S.). In the case of multiple publications on the same population, the main study was used as reference. If there were data queries, an attempt was made to contact the original study investigator. Data were extracted in a standardized manner by one author (G.C.).
If more than one customized approach was investigated in the same study, the model of Gardosi et al. [10] [11] [12] was chosen and compared with the population norms. If this model was not utilized, data obtained with the alternative customized growth approach were utilized.
Data reporting and risk of bias in individual studies
As only observational studies addressed our study question, we followed the guidelines for reporting meta-analyses and systematic reviews of observational studies 20 . Two authors (G.C. and M.M.C.) assessed the risk of bias of the included observational studies using the Cochrane Risk of Bias Tool for Non-Randomized Studies of Interventions (ACROBAT-NRSI) 21 . Disagreements were resolved by consensus.
Statistical analysis
A random-effects Bayesian meta-analysis was performed to compute pooled odds ratios (ORs) of adverse maternal and neonatal outcomes among SGA and LGA pregnancies, classified according to population-based or customized norms, when compared with non-SGA and non-LGA neonates, respectively. Compared with the frequentist approach, a Bayesian meta-analysis has several advantages, which include naturally accounting for the full uncertainty in all parameters, more easily interpretable inferences and inclusion of prior evidence of treatment effects or magnitudes 22, 23 . For outcomes for which all studies reported the number of cases and non-cases, Bayesian models assume that the number of adverse outcomes from each study follow a binomial distribution, with the probability of the outcome allowed to vary by study. For outcomes for which some studies reported only ORs and 95% CIs, the Bayesian models assume that log-transformed ORs from each study follow a normal distribution, with the mean representing the average logOR across all studies and variance indicating between-study variability. In all analyses, a neutral prior distribution centered at an OR of 1.0 with a 95% CI of 0.14-7.0 (normal distribution with mean of 0 and SD of 1 on the logOR scale) was used for the overall logOR. The range for this prior distribution excludes extremely large treatment effects that are almost never reported with clinical interventions 24, 25 . For the between-study SD, we used a weakly informative half-normal distribution (mean of 0 and SD of 0.65) consistent with reported heterogeneity in meta-analyses 26 . We report Bayesian estimates of study-specific and pooled ORs using the posterior median (given the skewed posterior distribution of the ORs, the median is preferred over the mean) and 95% CIs.
All analyses were implemented via Markov Chain Monte Carlo (MCMC) methods in OpenBUGS (version 3.2.3; www.openbugs.net/w/Downloads). For each model, we used three MCMC chains with 20 000 iterations after an initial burn-in of 10 000 iterations. Convergence was assessed and confirmed through visual inspection of trace plots of all parameters. Publication bias was not formally assessed because each analysis included fewer than 10 studies 27 .
RESULTS
A flowchart of the electronic search and selection process is shown in Figure 1 . We identified 237 potentially relevant publications and reviewed 27 articles for eligibility. The following adverse fetal and neonatal outcomes were addressed in the studies on SGA: IUFD 15, 16, [28] [29] [30] [31] [32] 39 , neonatal death 15, 16, 28, 33 , death in the NICU 16 , perinatal mortality [14] [15] [16] 28, 34, 35 , composite neonatal outcome 14, 17, [36] [37] [38] , NICU admission fat mass 43, 44 . Hypertensive disorders 15, 16, 33, 36, 41, 45 , preterm birth (indicated or spontaneous) 14 48, 49 , cervical lacerations 48 and postpartum hemorrhage 48 were the adverse maternal outcomes studied among LGA neonates.
A total of 20 studies (including 1 095 589 women) with usable outcome data were eligible for inclusion in our meta-analysis. No randomized controlled trial addressed the research question, therefore, only observational studies were included; their main characteristics are summarized in Table 1 . Abnormal growth was classified according to birth weight in all but two studies, which used ultrasound-estimated fetal weights 31, 39 . Infants were classified as SGA if birth weight was < 10 th centile for gestational age and LGA if birth weight was > 90 th centile for gestational age. Kase et al. 39 and Smith et al. 31 used the same cut-offs to define SGA and LGA, but the calculated growth percentiles were based on ultrasound-estimated fetal weight rather than on birth weight.
Customized centiles were obtained according to the approach described by Gardosi et al. [10] [11] [12] in all studies except that by Smith et al. 31 , which referred to the more complex model by Bukowski et al. 50 . In addition to maternal height, weight, parity, ethnic origin and gestational age at delivery that are included in the Gardosi method, the approach by Bukowski et al. 50 also takes into consideration prior pregnancies, marital status, maternal education and first-and second-trimester screening results. Population-based centiles were derived from sex-adjusted standards specific for the population enrolled in each study. Studies differed in their definitions of the various outcomes: Odibo et al. 29 and Moon et al. 32 explicitly defined IUFD as in-utero demise after 20 weeks' gestation, while Ego et al. 16 defined it as loss after 22 weeks. Ego et al. 16 defined perinatal death as stillbirth or death prior to NICU admission or during a stay in the NICU. Costantine et al. 17 defined NICU admission as a stay of > 48 h, while Odibo et al. 30 defined it as a stay of > 7 days.
Figures 2 and 3 show the data summary of each included study and the pooled OR estimates of the meta-analysis for each study outcome. There was evidence of study heterogeneity, with estimated between-study variability ranging from 0.03 to 0.65 for SGA analyses and 0.01 to 0.30 for LGA analyses, which are comparable with values reported in other meta-analyses 26 . However, the 95% CIs for this parameter were wide owing to the small number of studies included in the analyses.
The ORs of specific adverse perinatal outcomes were calculated, comparing SGA with non-SGA neonates and LGA with non-LGA neonates. Using population-based norms, SGA neonates were at higher risk for IUFD (OR, 3.3 (95% CI, 1.9-5.0)), neonatal death (OR, 2.9 (95% CI, 1.2-4.5)), perinatal death (OR, 4.0 (95% CI, 2.8-5.1)) and NICU admission (OR, 2.4 (95% CI, 1.7-3.2)). The corresponding ORs using customized growth charts were 7.8 (95% CI, 4.2-12.3) for IUFD, 3.5 (95% CI, 1.1-8.0) for neonatal death, 5.8 (95% CI, 3.8-7.8) for perinatal death and 3.6 (95% CI, 2.0-5.5) for NICU admission (Figure 2 ). According to population-based norms, LGA pregnancies had a similar risk of perinatal death (OR, 1.3 (95% CI, 0.5-3.3)), NICU admission (OR, 1.6 (95% CI, 0.8-2.3)), maternal third-and fourth-degree perineal lacerations (OR, 2.1 (95% CI, 0.9-3.4)) and neonatal hypoglycemia (OR, 1.6 (95% CI, 0.5-3.9)) when compared with non-LGA pregnancies. The corresponding ORs using customized growth charts were 1.6 (95% CI, 0.6-3.8) for perinatal death, 1.7 (95% CI, 0.9-2.5) for NICU admission, 2.6 (95% CI, 0.9-4.2) for maternal third-and fourth-degree perineal lacerations and 1.7 (95% CI, 0.5-3.9) for neonatal hypoglycemia. In contrast, LGA neonates were at higher risk for shoulder dystocia according to both population-based (OR, 8.0 (95% CI, 5.3-10.1)) and customized (OR, 7.4 (95% CI, 4.9-9.8)) norms ( Figure 3) . Table 2 shows the risk of bias according to the ACROBAT-NRSI 21 . Most included studies had a low overall risk of bias. Only three studies were ranked as having moderate or serious risk of bias 16, 33, 41 , as a large proportion of births were excluded from the analyses, in part owing to missing data.
DISCUSSION
Using either customized or population-based growth charts, SGA neonates appear to be at greater risk for IUFD, neonatal death, perinatal death and NICU admission than do non-SGA neonates. Although the point estimates between customized and population-based charts may differ for some outcomes, the CIs for these indirect comparisons overlap.
LGA pregnancies did not appear to be at increased risk for perinatal death, NICU admission, maternal third-/fourth-degree perineal lacerations or neonatal hypoglycemia compared with non-LGA pregnancies, using either customized or population-based growth charts. However, both approaches indicated an increased risk for shoulder dystocia among LGA neonates.
To our knowledge, this is the first meta-analysis evaluating adverse perinatal outcomes among SGA and LGA neonates identified by customized growth charts as compared with population-based norms. Our review has some limitations. As patient-level data were not Only first author of each study is given. SGA* and LGA † defined according to specific weight centiles for gestational age. BMI, body mass index; DM, diabetes mellitus; GA, gestational age; IUFD, intrauterine fetal demise; NR, not reported; NZ, New Zealand; PPROM, preterm prelabor rupture of the membranes; RCT, randomized controlled trial. 16 Gardosi (2009) 15 Hemming (2009) 28 Odibo (2011) 30 Odibo (2012) 29 Smith (2014) 31 Moon (2016) 32 Ego (2006) 16 Gardosi (2009) 15 Hemming (2009) 28 Odibo (2011) 30 Odibo (2012) 29 Smith (2014) 31 Moon (2016) 14 Ego (2006) 16 Odibo (2011) 30 Kase (2012) 39 van Eerd (2012) 41 Costantine (2013) 17 Khandaker (2014) 40 González-González (2015) 34 McCowan (2005) 14 Ego (2006) 16 Odibo (2011) 30 Kase (2012) 39 van Eerd (2012) 41 Costantine (2013) 17 Khandaker (2014) 40 González-González (2015) 34 Sovio (2015) 38 Sovio (2015) 29 and Costantine (2013) 17 did not report these for IUFD and NICU admission, respectively. Only first author of each study is given. OR, odds ratio. available, it was not possible to determine if the ORs for each outcome were significantly different when fetuses were classified by customized vs population-based norms. A customized approach led to higher ORs for the studied outcomes among SGA neonates when compared with population-based standards, suggesting that the criteria of the former classification may better identify patients at risk. However, any conclusion regarding the superiority of this method is hindered by the overlapping CIs.
No differences were detected when comparing LGA with non-LGA pregnancies regarding perinatal death, NICU admission, hypoglycemia and maternal third-/fourth-degree perineal lacerations, regardless of whether LGA was defined using customized or population-based growth charts, although macrosomia was associated with higher perinatal mortality and neonatal morbidity in a previous meta-analysis 51 . This seems to be because of the limited number of studies addressing these outcomes.
Most studies in this analysis used delivery data, while adverse outcomes such as IUFD, neonatal shoulder dystocia and maternal perineal lacerations occur before birth weight is known. However, customized models, like the one of Gardosi et al. [10] [11] [12] , utilize birth-weight data to elaborate a weight-for-gestational-age function to construct individual intrauterine weight curves. Evaluating differences in adverse outcomes when birth weight is outside the norm may provide a rationale for future studies aimed at assessing pregnancy complications when intrauterine fetal growth is followed prospectively according to customized, rather than population-based, standards.
As the model of Gardosi et al. [10] [11] [12] was the most commonly used one, we mainly compared this approach with population-based norms, notwithstanding that many other analytical methods for customizing fetal weight have been described and have been shown to perform even better 29, 48 . Through developmental programing, adult diseases can be linked to birth weight and the latter has been used as a measure of prenatal development 52 . Owing to the potential limitations of population-based norms 9, 10 , the use of other non-customized growth curves, such as the ones derived from the INTERGROWTH-21 st study, has been proposed 53 . This approach advocates the adoption of a universal standard for fetal growth, based on the rationale that optimal maternal conditions, in terms of education, nutrition and relative socioeconomic status, will lead to similar patterns of fetal growth, despite diverse cultural settings. Although the adoption of such a standard might seem to have the potential to make obstetric care more uniform, it does not consider the specific characteristics that make different populations unique 54 . In fact, application of the INTERGROWTH-21 st birth-weight standard to an obstetric population in New Zealand classified fewer infants as SGA, identifying fewer stillbirths and fewer cases of composite adverse neonatal outcomes than a customized standard based on the model of Gardosi et al. 55 . The differences in the relationship between maternal characteristics and fetal growth emphasize that one 34 Sjaarda (2014) 48 González-González (2015) 34 Sjaarda (2014) 48 PND:
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trajectory of fetal growth does not fit all and that evaluation of growth involves more than just assessment of size. In fact, recent reports have indicated that body composition may be a better measure of nutritional status than birth weight, as it also correlates with postnatal growth and subsequent health 56 .
The focus on intrauterine growth in the prevention of stillbirth is justified, as intrauterine growth restriction constitutes the largest single at-risk category among normally formed fetuses experiencing in-utero demise. Intrauterine growth restriction is also associated with increased risks of perinatal mortality, morbidity, cerebral palsy and long-term adverse health outcomes [1] [2] [3] 5, 6 . In most pregnancies with fetal growth restriction, the growth restriction is due to late-onset placental insufficiency and the babies are born at term. Antenatal recognition of this condition may lead to appropriate investigations and improved outcomes through antenatal testing and appropriate timing of delivery. In fact, it has been shown that the majority of deaths associated with fetal-growth problems are potentially avoidable through better assessment of risk factors and surveillance of growth during pregnancy 57, 58 . Our meta-analysis does not conclude that customized norms can better define a population of pathologically small fetuses that are at higher risk of adverse perinatal outcomes, although a recent prospective observational study suggested such a conclusion. Specifically, Gardosi et al. 59 reported that, in England, regions with a high uptake of an accreditation program in customized fetal growth experienced a significant reduction in stillbirths when compared with areas in which uptake was low.
Macrosomia is a common obstetric condition that has been associated with higher perinatal mortality and neonatal morbidity 4, 51 . Clinicians are often faced with deciding the appropriate route to deliver macrosomic fetuses in order to achieve the best maternal and neonatal outcome; moreover, these infants require closer postnatal surveillance to prevent complications such as hypoglycemia. Pre-emptive care has the potential for improving perinatal care through antenatal detection of pregnancies with macrosomic fetuses, which are at higher risk for complications. Our meta-analysis indicates that, with the exception of shoulder dystocia, neither customized nor population-based growth charts seem to identify macrosomic fetuses with a statistically significant risk of adverse outcomes. Given this result, it may be that absolute weight is more important in determining outcome in these large fetuses compared with an individualized approach.
Both customized and population-based growth charts can detect intrauterine growth disturbances that are associated with adverse perinatal outcomes, particularly for SGA neonates. Although point estimates of pooled ORs may differ for some of these outcomes, their overlapping CIs do not allow us to draw firm conclusions about the superiority of one method or the other in this indirect comparison. Future prospective randomized controlled trials are needed to determine whether applying this information would actually improve outcomes.
Gráficas de crecimiento personalizadas frente a gráficas basadas en la población para la identificación de neonatos con riesgo de un resultado adverso: revisión sistemática y metaanálisis bayesiano de estudios observacionales RESUMEN Objetivo Comparar la eficacia de las gráficas de crecimiento personalizadas frente a las gráficas basadas en la población para la predicción de resultados adversos del embarazo.
Métodos Se realizó una búsqueda en MEDLINE, ClinicalTrials.gov y The Cochrane Library hasta el 31 de mayo de 2016, para identificar estudios de intervención y de observación que habían comparado los resultados adversos entre neonatos grandes (GEG) y pequeños (PEG) para la edad gestacional, clasificados así mediante gráficas de crecimiento personalizadas frente a gráficas basadas en la población. Se evaluó: la mortalidad perinatal y la admisión a la unidad de cuidado intensivo neonatal (UCIN) de recién nacidos PEG y GEG; eléxitus intrauterino (IUFD, por sus siglas en inglés) y la mortalidad neonatal de neonatos PEG; la distocia de hombros y la hipoglucemia en los neonatos, así como desgarros perineales maternos de tercer y cuarto grado en embarazos GEG.
Resultados La búsqueda electrónica identificó 237 registros, en los cuáles se examinó el título y el resumen, y entre ellos se examinó la totalidad del texto de 27 artículos para evaluar su elegibilidad. Después de excluir siete artículos, se incluyeron 20 estudios observacionales en un metaanálisis bayesiano. Los neonatos clasificados como PEG de acuerdo con las gráficas de crecimiento personalizadas presentaron mayores riesgos de IUFD (razón de momios (RM) 7,8 (IC 95%, 4,2-12,3)), de muerte neonatal (RM 3,5 (IC 95%, 1,1-8,0), de muerte perinatal (RM 5,8 (IC 95%, 3,8-7,8) ) y de admisión en la UCIN (RM 3,6 (IC 95%, 2,0-5,5)), que los casos de neonatos que no eran PEG. Los neonatos clasificados como PEG de acuerdo a las tablas de crecimiento basadas en la población tuvieron un riesgo mayor de resultados adversos, aunque las estimaciones puntuales de las RM combinadas fueron más pequeñas: IUFD (RM 3,3 (95% CI, 1.9-5.0)), muerte neonatal (RM 2,9 (IC 95%, 1,2-4,5)), muerte perinatal (RM 4,0 (IC 95%, 2,8-5,1)), y admisión en la UCIN (RM 2,4 (IC 95%, 1,7-3,2)). La comparación entre GEG frente a no-GEG no mostró diferencias en las RM combinadas para la muerte perinatal, la admisión en la UCIN, la hipoglucemia y los desgarros perineales maternos de tercer y cuarto grado cuando se clasificaron de acuerdo con el enfoque personalizado o con el basado en la población. En contraste, ambos enfoques indicaron que los neonatos GEG tienen un mayor riesgo de distocia de hombros que los no GEG (RM 7,4 (IC 95%, 4,9-9,8) si se usan gráficas personalizadas, y RM 8,0 (IC 95%, 5,3-10,1) si se usan gráficas basadas en la población).
